Tag Archives: new drugs

Breast-Feeding May Protect Some Women Against Breast Cancer

  The Guardian Breast-Feeding May Protect Some Women Against BreastCancer Health.com ‎- “There are various explanations why breast-feeding seems to preventbreast cancer,” Gonzalez-Jimenez said. “The most probable of these are … read all at http://news.health.com/2013/08/15/breast-feeding-may-protect-some-women-against-breast-cancer/ By Kathleen Doheny HealthDay Reporter   Share this:

Posted in cancer | Tagged , , , , , , , , | Comments Off on Breast-Feeding May Protect Some Women Against Breast Cancer

Synthesis of cyclic carbonates with carbon dioxide and cesium carbonate

  Cyclic carbonates are important compounds for the synthesis of biocompatible polymers and linear dialkyl carbonates, as well as solvents and electrolytes. We report here the synthesis of such compounds from easily accessible starting materials with carbon dioxide as a … Continue reading

Posted in Uncategorized | Tagged , , , , , , , | Comments Off on Synthesis of cyclic carbonates with carbon dioxide and cesium carbonate

Even bacteria use social networks

  This model shows the role of vesicles, vesicle chains and membrane tubes in M. xanthus biofilms. The scientists believe these connections help cells exchange signals and material. Image: Auer laboratory Using several imaging techniques, Lawrence Berkeley National Laboratory scientists … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , , | Comments Off on Even bacteria use social networks

History of Cyclotides

Cyclotides are head-to-tail cyclic peptides in plants Cyclotides are plant-derived peptides of approximately 30 amino acids. They have the characteristic structural features of a head-to-tail cyclized backbone and a cystine knot arrangement of their three conserved disulfide bonds. Their unique … Continue reading

Posted in ORGANIC CHEMISTRY, SYNTHESIS, Uncategorized | Tagged , , , , , , , , , | Comments Off on History of Cyclotides

Marine Natural Products – Bioactivity & Chemical Ecology

Marine Natural Products – Bioactivity & Chemical Ecology allow slideshare to load……… Marine Natural Products – Bioactivity & Chemical Ecology [Kenneth Boyd, Martina Maria Burtscher & Robbie Mutton] from University of the Highlands and Islands Share this:

Posted in Uncategorized | Tagged , , , , , , , , , , , , , | Comments Off on Marine Natural Products – Bioactivity & Chemical Ecology

Coenzyme Q10

Coenzyme Q10 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl]-5, 6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione Coenzyme Q10 (ubiquinone-10, CoQ10, CoQ, Q10 or simply Q) is aubiquinone containing 10 isoprenoid units. First discovered in 1957 by Crane et al. [1], its chemical structure was determined by Karl Folkers [2], who later won the Priestley medal from the American Chemical Society. This … Continue reading

Posted in AYURVEDA, generic, herbals, ORGANIC CHEMISTRY, Uncategorized, VITAMINS | Tagged , , , , , , , , , | Comments Off on Coenzyme Q10

AVANAFIL, NEW DRUG FOR ERECTILE DYSFUNCTION, FDA APRIL 2012

Avanafil is a PDE5 inhibitor approved for erectile dysfunction on April 27, 2012.[1] Avanafil is known by the trademark name Stendra and was developed by Vivus Inc. It acts by inhibiting a specific phosphodiesterase type 5 enzyme which is found in various body tissues, but primarily in the corpus cavernosum penis, … Continue reading

Posted in DRUGS, Uncategorized | Tagged | Comments Off on AVANAFIL, NEW DRUG FOR ERECTILE DYSFUNCTION, FDA APRIL 2012

Sanofi Receives Positive CHMP Opinion in the European Union for Once-Daily Lyxumia® (lixisenatide)

Sanofi Receives Positive CHMP Opinion in the European Union for Once-Daily Lyxumia® (lixisenatide) Sanofi announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval … Continue reading

Posted in ORGANIC CHEMISTRY | Tagged | Comments Off on Sanofi Receives Positive CHMP Opinion in the European Union for Once-Daily Lyxumia® (lixisenatide)